NEW YORK (CNNMoney.com) -- The Food and Drug Administration has hit another Johnson & Johnson unit -- medical device maker DePuy Orthopaedics -- with a warning letter for selling hip and other joint products without the agency's approval.
The FDA said in the letter that the company has been selling its TruMatch Personalized Solutions System, which makes artificial knee products, and the Corail Hip System without "market clearance" and in violation of the Federal Food, Drug, and Cosmetic Act.
The agency said DePuy should immediately stop selling the Corail products or face further enforcement action, which could include product seizure, injunction or civil penalties.
The FDA said it will only evaluate whether these products can be legally marketed to consumers after DePuy submits information for approval.
The company's McNeil Consumer Healthcare unit, which makes well-known cold and pain drugs such as Tylenol and Benadryl, has received negative inspection reports and warning letters tied to manufacturing lapses at its U.S. factories.
In May, McNeil shut a plant in Fort Washington, Penn., after the company recalled millions of children's Tylenol and other drugs that were made at that facility.
In this latest warning letter, the FDA has given Depuy 15 days to correct the violations.
Lena Dunham steps into controversy again, this time for her recent New Yorker article in which she compares her Jewish boyfriend to a dog. More
A San Francisco judge ordered a jury in a high-profile Silicon Valley gender bias case to resume deliberating on Friday. The judge's decision came after he questioned the jurors and found they did not have an adequate majority on one of the plaintiff's four claims. More
Meet Luna, the tech-enabled mattress cover that just raised over $1.1 million on Indiegogo. More